<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0002986" disease_type="Disease or Syndrome" abbrv="">Fabry disease</z:e> is an X chromosome linked disorder caused by the inherited deficiency of lysosomal enzyme Î±-galactosidase A </plain></SENT>
<SENT sid="1" pm="."><plain>The deficiency results in abnormal degradation of certain <z:chebi fb="0" ids="24402">glycosphingolipids</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Although the disease is known for more than hundred years and the underlying molecular basis is getting to be well defined, there are still a lot of unanswered questions regarding the different clinical presentations, available diagnostic procedures and therapeutic interventions </plain></SENT>
<SENT sid="3" pm="."><plain>The scope of the article is to review the molecular basis of <z:e sem="disease" ids="C0002986" disease_type="Disease or Syndrome" abbrv="">Fabry disease</z:e> and summarize the available data about <z:e sem="disease" ids="C0002986" disease_type="Disease or Syndrome" abbrv="">Fabry disease</z:e> <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>, highlight the controversies of current knowledge and evaluate future research directions </plain></SENT>
</text></document>